本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Context Therapeutics Inc.

0.4386
-0.0268-5.76%
成交量:731.41萬
成交額:299.18萬
市值:4,029.82萬
市盈率:-0.91
高:0.4748
開:0.4700
低:0.3969
收:0.4654
52周最高:3.62
52周最低:0.3969
股本:9,187.92萬
流通股本:6,373.36萬
量比:4.45
換手率:11.48%
股息:- -
股息率:- -
每股收益(TTM):-0.4828
每股收益(LYR):-0.3800
淨資產收益率:-76.14%
總資產收益率:-45.70%
市淨率:1.06
市盈率(LYR):-1.15

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/31

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/23

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]